Mainboard · BSE and NSEDraft filed
Ujin Pharma Ltd. IPO: dates, price band, lot size, objects of the issue
Get updates on this IPO
Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.Too many attempts. Please wait a few minutes and try again.
Dates, allotment, listing and analyst views. Stop anytime.
By continuing you agree to the Terms and Privacy policy
Key facts
- Price band
- Not announced
- Lot size
- Not announced
- Lot amount at the upper band
- Not announced
- Issue size at the upper band
- 1,91,51,400 shares (Amount not stated in the draft)
- DRHP dated Mon 22 Jun 2026, page 1
- Bid dates
- Not announced
- Listing date
- Not announced
- Proposed exchanges
- BSE and NSE
Timeline (IST)
- Draft filedFri 26 Jun 2026 confirmedDRHP dated Mon 22 Jun 2026
- OpensDates to be announced
- ClosesDates to be announced
- AllotmentDates to be announced
- Refund and unblockDates to be announced
- ListingDates to be announced
Objects of the issue
| Object | Amount |
|---|---|
| Investment in Altra Agro-Chem Private Limited, our Associate Company, by way of subscription to equity shares for making it our Subsidiary | ₹61.72 crore |
| Investment in Altra Pharma-Chem Private Limited, our Associate Company, by way of subscription to equity shares for making it our Subsidiary | ₹21.64 crore |
| Repayment or pre-payment, in in part or full of certain borrowings availed by the Company from financial institutions | ₹25.00 crore |
| General Corporate Purposes | Not stated in the draft |
| Total | Not stated in the draft |
The offer for sale goes to the selling shareholders, not the company. DRHP dated Mon 22 Jun 2026, page 148
Company and promoters
As described in the DRHP
We are engaged in the distribution and supply of a diversified portfolio of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials and nutraceuticals.
DRHP dated Mon 22 Jun 2026, page 249
Promoters
- 3 individual promoters
DRHP dated Mon 22 Jun 2026, page 317
Shareholding
| Holding | Before the issue | After the issue |
|---|---|---|
| Promoters and promoter group | 83.73% | Not stated in the DRHP |
| Public | 16.28% | Not stated in the DRHP |
Basis: fully diluted
DRHP dated Mon 22 Jun 2026, pages 134 to 138
Who is selling in the offer for sale
| Selling shareholder | Type | Shares offered | Amount at the upper band |
|---|---|---|---|
| Individual shareholder | Individual | 36,41,150 | Not announced |
| Individual shareholder | Individual | 36,41,150 | Not announced |
| Total offer for sale | Not stated in the draft | ||
DRHP dated Mon 22 Jun 2026, page 1
Peer comparison (as in the DRHP)
| Name of the Company | Revenue from operations, for Fiscal 2025 (₹ in million) | Face Value (₹ per Share) | Closing price on June 12, 2026(₹)*** | P/E (1) | Basic EPS (In ₹) for Fiscal 2025 | Diluted EPS (In ₹) for Fiscal 2025 | RoNW (%) for Fiscal 2025 (2) | NAV (₹ per share) for Fiscal 2025 (3) |
|---|---|---|---|---|---|---|---|---|
| Ujin Pharma Limited* | Consolidated | 10 | [●] | [●] | 2.56 | 2.51 | 11.87% | 24.36 |
| Shiv Shakti | Standalone | 10 | 127.00 | 4.14 | 30.67 | 30.67 | 18.30 | 143.64 |
| Deepak Nitrite | Consolidated | 2 | 1670.1 | 32.67 | 51.12 | 51.12 | 13.61% | 397.70 |
| Balaji Amines | Consolidated | 2 | 2136.3 | 43.94 | 48.62 | 48.62 | 8.05% | 622.94 |
| Alkyl Amines Chemical Limited | Standalone | 2 | 1830.7 | 50.29 | 36.40 | 36.35 | 13.94% | 273.96 |
Reproduced from the DRHP dated Mon 22 Jun 2026, page 180; InsightPier adds no figures
Risk factors
77 total- Most revenue comes from the chemical distribution business (DRHP page 35)
- Reliance on imported chemical products exposes the company to supply, freight and currency disruptions (DRHP page 36)
- Purchases are concentrated among the top 10 suppliers (DRHP page 39)
- Foreign investment restrictions under Indian law may limit foreign investors (DRHP page 101)
- The shares have never traded publicly and their price may be volatile after listing (DRHP page 101)